Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication

BACKGROUND: All Helicobacter pylori-infected patients are recommended for eradication with an appropriate regimen in each geographic area. The choice of the therapy is somewhat dependent on the antimicrobial susceptibility. The rate of clarithromycin resistance has been increasing and is associated...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ann Clin Microbiol Antimicrob
Autores principales: Tanabe, Hiroki, Yoshino, Keiichi, Ando, Katsuyoshi, Nomura, Yoshiki, Ohta, Katsuhisa, Satoh, Kiichi, Ichiishi, Eiichiro, Ishizuka, Akiei, Otake, Takaaki, Kohgo, Yutaka, Fujiya, Mikihiro, Okumura, Toshikatsu
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6022507/
https://ncbi.nlm.nih.gov/pubmed/29950163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12941-018-0281-x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares